Clinical trial
MoleGazer: A Feasibility Study for Early Detection of Melanoma
NCT05015816 is registered in ClinicalTrials.gov with Oxford University Hospitals NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MoleGazer: A Feasibility Study for Early Detection of Melanoma
- Lead sponsor
- Oxford University Hospitals NHS Trust
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- September 13, 2021
- Completion date
- February 28, 2027
- Enrollment
- 374 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
melanoma (skin), moles multiple benign